MIRA INFORM REPORT

 

 

Report Date :

24.03.2011

 

IDENTIFICATION DETAILS

 

Name :

BERLIN  PHARMACEUTICAL  INDUSTRY  CO., LTD

 

 

Registered Office :

359  New  Road,  Pomprab,  Pomprabsatrupai, Bangkok  10100   

 

 

Country :

Thailand                       

 

 

Financials (as on) :

31.12.2009

 

 

Date of Incorporation :

07.08.1984

 

 

Com. Reg. No.:

0105527028430

 

 

Legal Form :

Private  Limited  Company

 

 

Line of Business :

Manufacturing  and  marketing  of  medical  and  pharmaceutical  products

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2010

 

Country Name

Previous Rating

(30.09.2010)

Current Rating

(31.12.2010)

Thailand

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Company name 

 

BERLIN  PHARMACEUTICAL  INDUSTRY  CO., LTD.

 

 

SUMMARY

 

BUSINESS  ADDRESS                          :           359  NEW  ROAD,  POMPRAB,  POMPRABSATRUPAI,

                                                                        BANGKOK  10100,  THAILAND                          

TELEPHONE                                         :           [66]  2225-4261-3 

FAX                                                      :           [66]  2225-4260,  2223-1011

E-MAIL  ADDRESS                                :           marketing@berlinpharm.com

REGISTRATION  ADDRESS                  :           SAME  AS  BUSINESS  ADDRESS

 

ESTABLISHED                         :           1984

REGISTRATION  NO.                           :           0105527028430 [Former: 2844/2527]

CAPITAL REGISTERED                         :           BHT.  19,607,840

CAPITAL PAID-UP                                :           BHT.  19,607,840

FISCAL YEAR CLOSING DATE              :           DECEMBER   31            

LEGAL  STATUS                                  :           PRIVATE  LIMITED  COMPANY

EXECUTIVE                                          :           MR. AMAL  K.  NAJ,  INDIAN

                                                                        CHIEF  EXECUTIVE  OFFICER  

 

NO.  OF  STAFF                                   :           450

LINES  OF  BUSINESS                          :           MEDICAL  AND  PHARMACEUTICAL  PRODUCTS

                                                                        MANUFACTURING  AND  MARKETING 

                                                                                                                                                 

                                                                         

CORPORATE  PROFILE

 

OPERATING  TREND                            :           STABLE                       

PRESENT  SITUATION                          :           OPERATING  NORMALLY                     

REPUTATION                                       :           GOOD  WITH  NORMAL  BUSINESS  ENGAGEMENT

MANAGEMENT  STANDARD                 :           MANAGEMENT  WITH  GOOD  PERFORMANCE                       

 

 

 

 


HISTORY

 

The  subject  was  established  on  August  7, 1984  as  a  private  limited  company under  the    name  BERLIN  PHARMACEUTICAL INDUSTRY CO., LTD.  by  Thai  groups,  in  order  to manufacture and market medical  and  pharmaceutical  products  for domestic  and overseas  markets.  It  currently  employs  450  staff.  

 

On July 12, 2002,  the  subject’s  name  was  changed  to  BERLIN  PHARMA [THAILAND]  CO., LTD.  However,  it  was  re-named  to  BERLIN  PHARMACEUTICAL  INDUSTRY  CO., LTD.  on  September  12,  2002.

 

The  subject’s  registered  address  is  359  New  Rd., Pomprab, Pomprabsatrupai, Bangkok 10100,   and   this  is  the  subject’s  current  operation  address.  

 

 

THE  BOARD  OF  DIRECTORS

 

     Name

 

Nationality

Age

 

 

 

 

Mr.  Termchai  Chainuwat

[x]

Thai

71

Mr. Suebchai  Chainuwat

 

Thai

67

Mrs.  Wanida  Chainuwat

[x]

Thai

70

Ms. Winda  Chainuwat

 

Thai

45

Mrs.  Lalana  Satesuban

 

Thai

66

Ms.  Choon  Vatanyuta

 

Thai

81

 

 

AUTHORIZED  PERSON

 

One  of  the  above  directors  [x]  can  sign  or  two  of  the  rest  directors  can  jointly  sign  on  behalf  of  the  subject  with  company’s  affixed.

 

 

MANAGEMENT

 

Mr. Amal  K. Naj  is  the  Chief  Executive  Officer.

He  is  Indian  nationality.

 

Mrs.  Lalana  Satesuban  is  the  Export  Manager.

She  is  Thai  nationality  with  the  age  of  66 years  old.

  

Mr.  Suraphan  Uransakul  is  the  Sales  Manager.

He  is  Thai  nationality.

 

Ms.  Sasithorn  Udomchaiteerakul  is  the   Factory   Manager.

She  is  Thai  nationality.

 


 

BUSINESS  OPERATIONS

 

The  subject  is  engaged  in  manufacturing  and  marketing  various  kinds  of  medical  and  pharmaceutical  products  including  powder  tablet,  capsule,  liquid,  ointment,  cream  and  gastrology  drug  and  etc. The  products  are  produced  under  the  standard  ISO and Foods  and  Drugs  Organization.

 

PURCHASE

 

Raw  materials are  purchased  from  suppliers  and  agents  both  local  and  overseas  countries  such  as  Germany, United States  of  America,  United  Kingdom,  France,  Japan,  India  and  Republic  of  China.

 

MAJOR  SUPPLIER

 

BASF  [Thai]  Ltd.          :  Thailand

 

SALES 

 

60% of  the products  are sold  locally  by wholesale to dealers and  end-users both  government  and  private  sector  nationwide.

 

EXPORT

 

40% of  the products are  exported  to Singapore,  India,  Laos, Myanmar, Vietnam,  Indonesia,  Hong  Kong,  Philippines,  Malaysia,  Taiwan,  South  Africa  and   Sri  Lanka.

 

 

SUBSIDIARY  AND  AFFILIATED  COMPANY

 

The  subject  is  not  found   to  have  any  subsidiary  nor  affiliated  company  here  in  Thailand.

 

 

LITIGATION

 

Bankruptcy  and  Receivership

 

There  are  no  litigation  on  bankruptcy  and  receivership  cases  filed  against  the  subject  found  at  Legal  Execution  Department  for  the  past  five  years.

 

Others

 

There  are  no  legal  suits  filed  against  the  subject  for  the  past  two  years.

 


CREDIT  

 

Sales  are  by  cash  or  on  the  credits  term  of  30-60  days.

Local  bills  are  paid  by  cash  or  on  the  credits  term  of  30-60  days.

Imports  are  by  L/C  at  sight  or  T/T  on  negotiated  term.

Exports  are  against  T/T  on  negotiated  term.

 

 

BUSINESS  TRANSACTION

 

The  products  are  sold  both  by  cash  and  credit  with  the  maximum  credit  given  at  30-60  days.  There  is  no  problem  on  its  account  receivable.

 

 

BANKING

 

Kasikornbank  Public  Co., Ltd.          

  [Head  Office : 1 Kasikorn  Lane,  Rajburana Rd.,  Rajburana,  Bangkok 10140]

 

Bangkok  Bank  Public  Co.,  Ltd.       

  [Head  Office :  333  Silom  Rd.,  Silom,  Bangrak,  Bangkok  10500]

 

Krung  Thai  Bank  Public  Co.,  Ltd.              

  [Head Office : 35  Sukhumvit  Rd.,  Klongtoeynua,  Wattana,  Bangkok  10110]

 

 

EMPLOYMENT

 

The  subject  employs  approximately  450  staff  [office  staff  and  factory  workers].

 

 

LOCATION  DETAILS

 

The  premise  is  rented  for  administrative  office  at  the  heading  address.  Premise  is  located  in  commercial   area.

 

Factory & warehouse was  located at 374  Romklao Rd., Klongsampraves,  Ladkrabang,  Bangkok 10520,    Tel : [66]  2360-8729.

 

Recently  the  factory  &  warehouse’s  address  has  been  changed  to  63  Moo 5, Romklao Rd., Klongsampraves,  Ladkrabang,  Bangkok 10520,  Tel:  [66] 2737-6717  Fax : [66]  2360-8729.   [Only  the  address  number  has  been  changed,  but  they  are  the  same  location.]

 

REMARK

 

CREDIT  OF  US$  125,000  AGAINST  DA  TERMS  SHOULD  BE  IN  ORDER.

 

 

COMMENT

 

Since the subject has  been  established in Thailand more  than  20  years,  its products have been well accepted  from  both   local  and  international  markets  with  steady  growth each year.  The company’s  productions are  properly run  by expertise  with an  outstanding  performance. 

 

The  subject  has  been   enjoying  its  excellent  business  and  expanding  steadily.  

 

 

FINANCIAL  INFORMATION

 

The  capital  was  initially registered  at  Bht. 1,000,000  divided  into 100,000 shares  of  Bht.  10  each.

 

The  capital  was  increased  later  as  following:

 

            Bht.     5,000,000  on  October  25,  1985

            Bht.   10,000,000  on  October  31,  1989 

            Bht    19,607,840  on  December  29,  2008

           

The  latest  registered  capital  was  increased  to Bht. 19,607,840 divided  into 1,960,784  shares  of  Bht.  10  each  with  fully  paid.

 

 

THE  SHAREHOLDERS  LISTED  WERE

 [as  at  October  11,  2010]

 

       NAME

HOLDING

%

 

 

 

Green  Stem  Limited

Nationality:  Hong  Kong

Address     :  41st Flr.,  Bank  of  China,  1  Garden  Rd., 

                     Central,  Hong  Kong

910,785

46.45

Ms.  Winda  Chainuwat

Nationality:  Thai

Address     :  458/1-3  Rama 1 Rd., Pathumwan,

                     Bangkok  10330   

180,000

9.18

Mr.  Athisit  Chainuwat

Nationality:  Thai

Address     :  8/2  Sukhumvit  49  Rd., Prakanong,

                      Bangkok 10110  

100,000

5.10

Mr.  Suebchai  Chainuwat

Nationality:  Thai

Address     :  18  Sukhumvit  35  Rd.,  Klongton, 

                     Prakanong,  Bangkok                  

100,000

5.10

Mr. Termchai  Chainuwat

Nationality:  Thai

Address     :  458/1-3  Rama 1 Rd., Pathumwan,

                     Bangkok  10330

100,000

5.10

 

 

 

Ms.  Wanida  Chainuwat

Nationality:  Thai

Address     :  458/1-3  Rama 1 Rd., Pathumwan,

                     Bangkok  10330

99,999

5.10

Mr. Nathachai  Chainuwat

Nationality:  Thai

Address     :  8/2  Sukhumvit  49 Rd., Prakanong,

                     Bangkok 10110     

80,000

4.08

Ms. Maneechay  Chainuwat

Nationality:  Thai

Address     :  8/2  Sukhumvit  49 Rd.,  Prakanong,

                     Bangkok 10110     

80,000

4.08

Ms.  Sivaporn  Chainuwat

Nationality:  Thai

Address     :  458/1-3  Rama  1 Rd.,  Pathumwan,

                     Bangkok 10330       

80,000

4.08

Mr.  Ekachai  Chainuwat

Nationality:  Thai 

Address     :  458/1-3  Rama  1 Rd.,  Pathumwan,

                     Bangkok 10330

80,000

4.08

Mrs. Thiparat  Chainuwat

Nationality:  Thai 

Address     :  18 Sukhumvit  35 Rd.,  Klongton,  Prakanong,

                     Bangkok

80,000

4.08

Mr. Amal  K. Naj

Nationality:  Indian

Address     :  56/3  Moo  2,  Klongchan,  Bangkapi, 

                     Bangkok

50,000

2.55

Ms. Lalana  Setasuwan

Nationality:  Thai 

Address     :  56/3  Moo  2,  Klongchan,  Bangkapi, 

                     Bangkok

10,000

0.51

Ms.  Choon  Vatanyuta

Nationality:  Thai 

Address     :  1764/1  Rama 6  Rd.,  Rongmuang,

                     Pathuman,  Bangkok

10,000

0.51

 

Total  Shareholders  :    14

 

NAME  OF  AUDITOR  &  CERTIFIED  PUBLIC  ACCOUNTANT  NO.

 

Mr.  Kasem  Thoonkrisana No.  5643

          

 

BALANCE SHEET [BAHT]

 

The  latest  financial  figures  published  for  December  31,  2009  &  2008  were:

          

ASSETS

                                                                                                

Current Assets

2009

2008

 

 

 

Cash  and  Cash  Equivalents     

270,293,343.81

180,554,743.43

Short  Term  Investment

69,483,334.11

69,463,732.56

Trade  Accts.  Receivable

463,999,577.39

426,915,405.92

Short-term  Loan  to  Person  or Related  

   Company

 

 -

 

17,166.20

Inventories                                  

146,052,536.15

147,811,442.31

Other  Current  Assets                

59,615,974.06

59,147,011.62

 

 

 

Total  Current  Assets                

1,009,444,765.52

883,909,502.04

 

Long  Term  Loan  to  Person  or  Related 

  Company

 

 

16,655,969.06

 

 

5,039,015.44

Investment  in  Related  Company

3,490,024.00

3,490,024.00

Long  Term  Investment

18,289,686.00

18,289,686.00

Fixed Assets                              

308,717,308.17

253,694,551.02

Intangible  Assets                       

1,149,521.01

2,808,522.33

Other  Assets                           

12,084,078.91

32,344,091.98

 

Total  Assets                 

 

1,369,831,352.67

 

1,199,575,392.81


 

LIABILITIES & SHAREHOLDERS' EQUITY [BAHT]

 

 

Current Liabilities

2009

2008

 

 

 

Trade  Accts.  Payable

126,908,180.30

127,520,599.90

Hire-Purchase  Payable

10,297,383.00

9,285,257.00

Other  Current  Liabilities             

298,025,752.14

280,967,893.94

 

 

 

Total Current Liabilities

435,231,315.44

417,773,750.84

 

 

 

Other  Long  Term  Loans

-

893,379.86

 

Total  Liabilities            

 

435,231,315.44

 

418,667,130.70

 

 

 

Shareholders' Equity

 

 

 

 

 

 Share  capital : Baht  10  par  value 

  authorized,  issued  and  fully 

  paid  share  capital  1,960,784  shares

 

 

19,607,840.00

 

 

19,607,840.00

 

 

 

Capital  Paid                      

19,607,840.00

19,607,840.00

Statutory  Reserve

2,000,000.00

1,000,000.00

Loss  from  Change  Value  of  Investment

[194,214.00]

[194,214.00]

Retained  Earning - Unappropriated                

913,186,411.23

760,494,636.11

 

Total Shareholders' Equity

 

934,600,037.23

 

780,908,262.11

 

Total Liabilities  &  Shareholders'  Equity

 

1,369,831,352.67

 

1,199,575,392.81


                                                  

PROFIT  &  LOSS  ACCOUNT

 

Revenue

2009

2008

 

 

 

Sales                                         

1,531,182,739.86

1,466,310,137.88

Gain  on  Exchange  Rate

3,597,750.00

-

Gain  from  Sale  of  Assets

2,416,272.46

1,118,058.00

Other  Income                 

6,018,127.52

9,833,325.30

 

Total  Revenues           

 

1,543,214,889.84

 

1,477,261,521.18

 

Expenses

 

 

 

 

 

Cost  of  Goods  Sold                  

681,294,429.65

689,177,629.79

Selling  &  Administrative  Expenses

393,925,381.33

392,598,057.42

Loss  from  Exchange  Rate       

208,581,264.97

174,766,209.62

Loss  on  Exchange Rate

-

223,071.35

 

Total Expenses             

 

1,283,801,075.95

 

1,256,764,968.18

 

 

 

Profit / [Loss]  from  Operation

259,413,813.89

220,496,553.00

Interest  Expenses

[643,091.11]

[891,625.91]

 

Profit/[Loss] before Income Tax

 

258,770,722.78

 

219,604,927.09

Income  Tax

[34,059,347.66]

[31,542,036.48]

 

Net  Profit / [Loss]

 

224,711,375.12

 

188,062,890.61

 

 


 

FINANCIAL  ANALYSIS

 

ITEM

UNIT

2009

2008

 

 

 

 

LIQUIDITY RATIO

 

 

 

CURRENT RATIO

TIMES

2.32

2.12

QUICK RATIO

TIMES

1.85

1.62

 

 

 

 

ACTIVITY RATIO

 

 

 

FIXED ASSETS TURNOVER

TIMES

4.96

5.78

TOTAL ASSETS TURNOVER

TIMES

1.12

1.22

INVENTORY CONVERSION PERIOD

DAYS

78.25

78.28

INVENTORY TURNOVER

TIMES

4.66

4.66

RECEIVABLES CONVERSION PERIOD

DAYS

110.61

106.27

RECEIVABLES TURNOVER

TIMES

3.30

3.43

PAYABLES CONVERSION PERIOD

DAYS

67.99

67.54

CASH CONVERSION CYCLE

DAYS

120.86

117.02

 

 

 

 

PROFITABILITY RATIO

 

 

 

COST OF GOODS SOLD

%

44.49

47.00

SELLING & ADMINISTRATION

%

25.73

26.77

INTEREST

%

0.04

0.06

GROSS PROFIT MARGIN

%

56.29

53.75

NET PROFIT MARGIN BEFORE EX. ITEM

%

16.94

15.04

NET PROFIT MARGIN

%

14.68

12.83

RETURN ON EQUITY

%

24.04

24.08

RETURN ON ASSET

%

16.40

15.68

EARNING PER SHARE

BAHT

114.60

95.91

 

 

 

 

LEVERAGE RATIO

 

 

 

DEBT RATIO

TIMES

0.32

0.35

DEBT TO EQUITY RATIO

TIMES

0.47

0.54

TIME INTEREST EARNED

TIMES

403.39

247.30

 

 

 

 

ANNUAL GROWTH

 

 

 

SALES GROWTH

%

4.42

 

OPERATING PROFIT

%

17.65

 

NET PROFIT

%

19.49

 

FIXED ASSETS

%

21.69

 

TOTAL ASSETS

%

14.19

 

 


 

PROFITABILITY RATIO

 

Gross Profit Margin

56.29

Impressive

Industrial Average

33.03

Net Profit Margin

14.68

Impressive

Industrial Average

(22.69)

Return on Assets

16.40

Impressive

Industrial Average

(3.40)

Return on Equity

24.04

Impressive

Industrial Average

2.71

 

Gross Profit Margin used to assess a firm's financial health by revealing the proportion of money left over from revenues after accounting for the cost of goods sold. Gross profit margin serves as the source for paying additional expenses and future savings. Gross Profit Margin is 56.29%. When compared with the industry average, the ratio of the company was higher, indicated that company was more profitable than the same industry.

 

Net Profit Margin is the indicator of the company's efficiency in that net profit takes into consideration all expenses of the company. A low profit margin indicates a low margin of safety, higher risk that a decline in sales will erase profits and result in a net loss. Net Profit Margin is 14.68% compared with those of its average competitors in the same industry, indicated that business was an efficient operator in a dominant position within its industry.

 

Return on Assets measures how efficiently profits are being generated from the assets employed in the business when compared with the ratios of firms in a similar business. A low ratio in comparison with industry averages indicates an inefficient use of business assets. Return on Assets  is 16.4%, higher figure when compared with those of its average competitors in the same industry, indicated that business was an efficient profit in a dominant position within its industry.

 

Return on Equity indicates how profitable a company is by comparing its net income to its average shareholders' equity, ROE measures how much the shareholders earned for their investment in the company. Return on Equity is 24.04%, higher figure when compared with those of its average competitors in the same industry, indicated that business was an efficient profit in a dominant position within its industry.

 

Trend of the average competitors in the same industry for last 5 years

Return on Assets                       Downtrend

Return on Equity                        Downtrend

 

 

LIQUIDITY RATIO

 

Current Ratio

2.32

Deteriorated

Industrial Average

38.80

Quick Ratio

1.85

 

 

 

Cash Conversion Cycle

120.86

 

 

 

 

The Current Ratio is to ascertain whether a company's short-term assets are readily available to pay off its short-term liabilities. The company's figure is 2.32 times in 2009, increase from 2.12 times, then it is generally considered to have good short-term financial strength. When compared with the industry average, the ratio of the company was lower.

 

The Quick Ratio is a liquidity indicator that further refines the current ratio by measuring the amount of the most liquid current assets there are to cover current liabilities. The company's figure is 1.85 times in 2009, increase from 1.62 times, although excluding inventory so the company still have good short-term financial strength.

 

The Cash Conversion Cycle measures the number of days a company's cash is tied up in the production and sales process of its operations and the benefit from payment terms from its creditors. It meant the company could survive when no cash inflow was received from sale for 121 days.

 

Trend of the average competitors in the same industry for last 5 years

Current Ratio                 Uptrend

 


 

 

 

LEVERAGE RATIO

 

Debt Ratio

0.32

Impressive

Industrial Average

0.73

Debt to Equity Ratio

0.47

Impressive

Industrial Average

1.57

Times Interest Earned

403.39

Impressive

Industrial Average

304.70

 

Debt to Equity Ratio a measurement of how much suppliers, lenders, creditors and obligors have committed to the company versus what the shareholders have committed. A lower the percentage means that  the company is using less leverage and has  stronger equity position.

 

Times Interest Earned measuring a company's ability to meet its debt obligations. Ratio is 403.39 higher than 1, so the company can pay interest expenses on outstanding debt.

 

Debt Ratio shows the proportion of a company's assets which are financed through debt. The company's figure is 0.32 less than 0.5, most of the company's assets are financed through equity.

 

Trend of the average competitors in the same industry for last 5 years

Debt Ratio                                 Uptrend

Times Interest Earned                Uptrend

 

 

ACTIVITY RATIO

 

Fixed Assets Turnover

4.96

Deteriorated

Industrial Average

432.48

Total Assets Turnover

1.12

Impressive

Industrial Average

1.11

Inventory Conversion Period

78.25

 

 

 

Inventory Turnover

4.66

Acceptable

Industrial Average

6.94

Receivables Conversion Period

110.61

 

 

 

Receivables Turnover

3.30

Deteriorated

Industrial Average

11.87

Payables Conversion Period

67.99

 

 

 

 

Trend of the average competitors in the same industry for last 5 years

Fixed Assets Turnover                Uptrend

Total Assets Turnover                 Downtrend

Inventory Turnover                      Uptrend

Receivables Turnover                  Uptrend

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.96

UK Pound

1

Rs.73.56

Euro

1

Rs.63.68

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.